BASEC ID Project title Type of project Type of clinical trial Study phase (clinical trials only) multi- / monocentric Category Principal investigator Sponsor Investigational sites Lead EC Local EC(s) Approval date Minors Study Ended
2022-D0074 Validation of CPM#1 compressibility ratio in a clinical study of healthy volunteers: evaluation of the test-retest reliability clinical trial medical devices monocentric C2 Dr med Beat Lehmann Compremium AG Inselspital Bern, Bern
Kantonale Ethikkommission Bern 25.10.2022 Study has ended
2022-D0068 A Protocol Comparing Temporary Transvenous Diaphragm
Pacing to Standard of Care for Weaning from Mechanical
Ventilation in ICD Patients (RESCUE 3)
clinical trial medical devices monocentric C2 Dr. med. Philipp Bühler Lungpacer Medical, Inc. University Hospital, Zurich
Kantonale Ethikkommission Zürich 02.09.2022 Study has ended
2022-D0022 Clinical validation of CPM#1 compression ratio measurement on healthy volunteers clinical trial medical devices monocentric C2 Dr Helen Anwander Compremium AG Inselspital Bern, Bern
Kantonale Ethikkommission Bern 02.05.2022 Study has ended
2022-01761 Collection of retrospective, de-identified renal function data in patients with Fabry disease and not on enzyme replacement therapy personal data/biological material monocentric PD Dr med Albina Nowak Competitive Drug Development International Ltd University Hospital Zurich, Zurich
Kantonale Ethikkommission Zürich 07.11.2022 Study has ended
2022-01456 Validation of different technologies in terms of heart rate, heart rate variability, activity recognition and core body temperature estimations non clinical, involving persons monocentric A Dr. rer. nat. Rahel Gilgen-Ammann Eidg. Hochschule für Sport Magglingen EHSM Eidg. Hochschule für Sport Magglingen EHSM , Bundesamt für Sport BASPO, Magglingen
Kantonale Ethikkommission Bern 20.09.2022 Study has ended
2022-01347 Bioavailability study of a mesalazine formulation of 1200 mg gastro-resistant prolonged release tablets versus the marketed product Mesavancol® administered to healthy volunteers under fed conditions clinical trial drugs phase 1 monocentric C Dr. Milko Radicioni Mogon Pharmaceuticals Sagl CROSS Research S.A. Phase I Unit, CH-6864 Arzo, Switzerland
Comitato etico cantonale Ticino 11.08.2022 Study has ended
2022-01331 Facteur von Willebrand: possible implication dans la thrombose intra-stent coronarienne (Von Willebrand Factor: involvement in intra-strent coronary thrombosis) (FAIR3) personal data/biological material monocentric Prof. Dr. med. Lorenzo Alberio CHUV - BH18 619 CHUV, Lausanne
Commission cantonale d'Éthique de la Recherche sur l'être humain Vaud (CER-VD) 02.08.2022 Study has ended
2022-01325 HEAT stress detection from personally STandARdized heat strain measurements – The HEATSTAR pilot trial non clinical, involving persons monocentric A Dr. med. Noé Brasier Institute of Translational Medicine ITM, ETH Zurich, Zurich
Ethikkommission Nordwest- und Zentralschweiz EKNZ 03.11.2022 Study has ended
2022-01317 Bioequivalence study of a new ibuprofen arginine 600 mg tablet formulation versus ibuprofen arginine 600 mg sachet in healthy volunteers clinical trial drugs phase 1 monocentric C Dr Milko Radicioni Zambon S.p.A. CROSS Research S.A. Phase I Unit, Arzo, Switzerland
Comitato etico cantonale Ticino 11.08.2022 Study has ended
2022-01129 Les neuroleptiques et le risque de chutes en post-opératoire chez les adultes hospitalisé-e-s : une étude rétrospective de cas-témoins. personal data/biological material monocentric Dr. Nancy Helou HESAV HESAV, Lausanne
Commission cantonale d'Éthique de la Recherche sur l'être humain Vaud (CER-VD) 10.08.2022 Study has ended
2022-01105 Identification of a brain oxygenation marker for cognition using functional Near Infrared Spectroscopy in healthy adults non clinical, involving persons monocentric A Dr Pamela Sun Société des Produits Nestlé S.A Société des Produits Nestlé SA, Lausanne
Commission cantonale d'Éthique de la Recherche sur l'être humain Vaud (CER-VD) 26.08.2022 Study has ended
2022-01033 Romiplostim for thrombocytopenia induced by lomustine at first progression of MGMT promoter-methylated glioblastoma: a randomized phase II open label multicenter study clinical trial drugs phase 2 multicentric C Dr. Patrick Roth European Organisation for Research and Treatment of Cancer (EORTC) UniversitaetsSpital Zurich - Neurology Clinic, Zurich
Oncology Institute of Southern Switzerland - Ospedale San Giovanni, Bellinzona
Kantonale Ethikkommission Zürich Comitato etico cantonale Ticino 15.11.2022 Study has ended
2022-00972 Dry Needling and force change - Does dry needling on the M. gluteus maximus have a positive effect on jumping power clinical trial other clinical trials monocentric A Vanessa Di Marzo Therapie Ostschweiz GmbH, St. Gallen
Ethikkommission Ostschweiz (EKOS) 16.06.2022 Study has ended
2022-00939 Esperienza e utilità percepita dai pazienti che hanno ricevuto il diario della degenza in terapia intensiva: uno studio qualitativo non clinical, involving persons monocentric A Infermiere Michele Villa Istituto Cardiocentro Ticino - EOC Istituto Cardiocentro Ticino - EOC, Lugano
Comitato etico cantonale Ticino 09.06.2022 Study has ended
2022-00937 Switching COPD Patients from Spiriva® HandiHaler® maintenance therapy to Spiriva® Respimat®: a non-Interventional Real-world clinicAl ouTcome assEssment: NIS PIRATE non clinical, involving persons multicentric A Prof. Dr. med. Joerg Leuppi Boehringer Ingelheim Kantonsspital Baselland, Liestal
Praxis, Sierre
Praxis Weissenaustrasse 27, 3800 Unterseen
Cabinet Dr. Jean-Frédéric Vodoz, Montreux
Zürcher Reha Zentren Wald, Wald
Spital Uster, Uster
Stadtspital Zür More ...
Ethikkommission Nordwest- und Zentralschweiz EKNZ Kantonale Ethikkommission Bern, Kantonale Ethikkommission Zürich, Commission cantonale d'Éthique de la Recherche sur l'être humain Vaud (CER-VD) 26.07.2022 Study has ended
2022-00923 Comparative bioavailability study of a new Lorazepam IBSA 2.5 mg orodispersible film vs. Tavor® 2.5 mg tablets and Tavor® 2.5 mg orodispersible tablets in healthy volunteers under fasting conditions clinical trial drugs phase 1 monocentric C Dr. Milko Radicioni IBSA Institut Biochimique S.A. CROSS Research S.A. Phase I Unit, CH-6864 Arzo, Switzerland
Comitato etico cantonale Ticino 09.06.2022 Study has ended
2022-00872 Contrast agent determination in human blood cells – A pilot study non clinical, involving persons monocentric A Dr. Nico Olivier Ruprecht Inselspital Inselspital, Bern
Kantonale Ethikkommission Bern 09.08.2022 Study has ended
2022-00839 The use of chiasmopexy for the treatment of skull base meningiomas personal data/biological material monocentric Professor Roy Daniel Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne
Commission cantonale d'Éthique de la Recherche sur l'être humain Vaud (CER-VD) 14.07.2022 Study has ended
2022-00815 Bewegungsbeobachtung und -vorstellung in Kombination mit Nervenstimulation als Intervention bei Hirnschlagbetroffenen mit eingeschränkter oberer Extremität: eine Pilotstudie clinical trial other clinical trials monocentric A Frank Behrendt Reha Rheinfelden Reha Rheinfelden, Research Department, Rheinfelden
Ethikkommission Nordwest- und Zentralschweiz EKNZ 05.07.2022 Study has ended
2022-00792 ETV6 rearrangements and deletions: rare events in myeloid malignancies. A case series of a single centre and review of the literature personal data/biological material monocentric Dr Vasiliki Papadopoulou CHUV Centre Hospitalier Universitaire Vaudois, Lausanne
Commission cantonale d'Éthique de la Recherche sur l'être humain Vaud (CER-VD) 19.05.2022 Study has ended